ALT: Elevated https://greenmedinfo.com/taxonomy/term/6545/all en Blueberry leaf extract reduces fasting glucose, C-reactive protein and plasma aminotransferases in patients with diabetes type 2. https://greenmedinfo.com/article/blueberry-leaf-extract-reduces-fasting-glucose-c-reactive-protein-and-plasma-a PMID:  Georgian Med News. 2006 Dec;(141):66-72. PMID: 17261891 Abstract Title:  Effect of Blueberin on fasting glucose, C-reactive protein and plasma aminotransferases, in female volunteers with diabetes type 2: double-blind, placebo controlled clinical study. Abstract:  In a 4-week randomized placebo-controlled clinical trial we investigated the effect of 300 mg Blueberin, a phytomedicine containing 250 mg Blueberry leaves (Vaccinium arctostaphylos L, Ericaceae) extract providing minimum 50 mg 3,4-caffeoylquinic (chlorogenic) acid, and 50 mg myricetin, on fasting plasma glucose, alanine aminotransferases (ALT), aspartate aminotransferases (AST), glutamyltransferase (GGT) enzymes levels, and serum inflammatory C-Reactive proteins (CRP) in forty-two volunteer subjects (46+/-15 year of age, BMI 25+/-3 kgs/(m2)) diagnosed with Type 2 diabetes. During the 4-week trial, the Blueberin supplement was administered three times per day, 15-30 minutes prior to a meal along with 100 ml of water. Results of this trial revealed that the supplementation of Blueberin reduced fasting plasma glucose from 143+/-5,2mg/L to 104+/-5,7 mg/L (p&lt;0,001), whereas there was no statistically significant changes in the Placebo group from 138+/-4,8 mg/L to 126+/-5,1mg/L (p&gt;0,05). The reduction of fasting glucose was correlated with the reduction of serum CRP and in the Blueberin group from 5,18+/-1,4 mg/l to 2,14+/-1,8 mg/L (p&lt;0,05), whereas in the Placebo group CRP levels were not significantly reduced from 5,11+/-1,7 mg/l to 4,94+/-1,1mg/L (p&gt;0,05). Furthermore, the Blueberin also significantly reduced the levels of plasma enzymes ALT, AST and GGT, indicating that, in addition to anti-diabetes effects, the Blueberin also possess pharmacologically relevant anti-inflammatory properties. https://greenmedinfo.com/article/blueberry-leaf-extract-reduces-fasting-glucose-c-reactive-protein-and-plasma-a#comments ALT: Elevated Blueberry C-Reactive Protein Diabetes Mellitus: Type 2 GGT Results for Liver Enzymes: Elevated AST Anti-Inflammatory Agents Human Study Mon, 20 Apr 2009 06:06:59 +0000 greenmedinfo 41033 at https://greenmedinfo.com Carvacrol normalizes elevated liver enzymes induced by d-galactosamine-induced hepatotoxicity in rats. https://greenmedinfo.com/article/carvacrol-normalizes-elevated-liver-enzymes-induced-d-galactosamine-induced-he PMID:  Fundam Clin Pharmacol. 2009 Dec;23(6):757-65. Epub 2009 Jul 24. PMID: 19650854 Abstract Title:  Effect of carvacrol on hepatic marker enzymes and antioxidant status in D-galactosamine-induced hepatotoxicity in rats. Abstract:  Carvacrol (2-methyl-5-(1-methylethyl)-phenol) is a predominant monoterpenic phenol which occurs in many essential oils of the family Labiatae including Origanum, Satureja, Thymbra, Thymus, and Corydothymus species. This study was designed to investigate the hepatoprotective and antioxidant properties of carvacrol on D-galactosamine (D-GalN)-induced hepatotoxicity and oxidative damage in male albino Wistar rats. D-GalN hepatotoxic rats exhibited elevation in the activities of aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, gamma-glutamyl transpeptidase, and lipidperoxidative markers such as thiobarbituric acid reactive substances (TBARS) and lipid hydroperoxides. Activities of enzymatic antioxidants (superoxide dismutase, catalase, and glutathione peroxidase) and the levels of non-enzymatic antioxidants (vitamin C, vitamin E, and reduced glutathione) in the plasma, erythrocytes, liver, and kidney decreased in the hepatotoxic rats. Oral administration of carvacrol for 21 days brought these parameters towards normal. The biochemical observations were supported by histological studies of rat liver and kidney tissues. These results suggest that carvacrol could afford a significant hepatoprotective and antioxidant effect against D-GalN-induced rats. https://greenmedinfo.com/article/carvacrol-normalizes-elevated-liver-enzymes-induced-d-galactosamine-induced-he#comments ALT: Elevated Carvacrol Chemically-Induced Liver Damage Gamma-glutamyl transpeptidase: Elevated Oxidative Stress Antioxidants Hepatoprotective Animal Study Fri, 16 Apr 2010 00:50:11 +0000 greenmedinfo 54922 at https://greenmedinfo.com Chrysin has a positive influence on hepatic marker enzymes in chemically-induced liver toxicity in rats. https://greenmedinfo.com/article/chrysin-has-positive-influence-hepatic-marker-enzymes-chemically-induced-liver PMID:  Food Chem Toxicol. 2010 Mar 31. Epub 2010 Mar 31. PMID: 20362027 Abstract Title:  Influence of chrysin on hepatic marker enzymes and lipid profile against D-galactosamine-induced hepatotoxicity rats. Abstract:  Chrysin is a flavonoid that exists in nature and is the major component of some traditional medicinal herbs. We investigated the hepatoprotective and antihyperlipidaemic potential of chrysin against D-galactosamine (a single intraperitoneal injection 400mg/kgBW) induced hepatotoxicity in male albino Wistar rats. D-GalN rats exhibited an increased hepato and nephro toxicity marker activities aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase and gamma glutamyl transpeptidase and total bilirubin level while urea, uric acid and creatinine and lipid profile. It also negatively affected the serum total protein, albumin and A/G ratio. Rats treated with chrysin at different concentrations (25, 50 and 100mg/kgBW) caused a significant improvement in serum protein level, decreased hepato and nephro toxicity markers. It also decreased the levels of very low density lipoprotein cholesterol and low density lipoprotein cholesterol while high density lipoprotein cholesterol significantly increased. It also decreased the levels of total cholesterol, phospholipids, triglycerides, free fatty acids in the plasma and tissues of liver and kidney. The effect of chrysin (25mg/kg) is comparable with silymarin, a known hepatoprotective drug. Chrysin thus exhibits hepatoprotective and antihyperlipidaemic activity. https://greenmedinfo.com/article/chrysin-has-positive-influence-hepatic-marker-enzymes-chemically-induced-liver#comments ALT: Elevated Chemically-Induced Liver Damage Chrysin Gamma-glutamyl transpeptidase: Elevated GGT Results for Liver Enzymes: Elevated AST Hepatoprotective Animal Study Fri, 16 Apr 2010 00:25:14 +0000 greenmedinfo 54918 at https://greenmedinfo.com Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people. https://greenmedinfo.com/article/diverse-effects-low-dose-supplement-lipidated-curcumin-healthy-middle-aged-peo PMID:  Nutr J. 2012 Sep 26 ;11(1):79. Epub 2012 Sep 26. PMID: 23013352 Abstract Title:  Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people. Abstract:  ABSTRACT: BACKGROUND: Curcumin extracts of turmeric are proposed to produce health benefits. To date, human intervention studies have focused mainly on people with existing health problems given high doses of poorly absorbed curcumin. The purpose of the current study was to check whether in healthy people, a low dose of a lipidated curcumin extract could alter wellness-related measures. METHODS: The present study was conducted in healthy middle aged people (40--60 years old) with a low dose of curcumin (80 mg/day) in a lipidated form expected to have good absorption. Subjects were given either curcumin (N = 19) or placebo (N = 19) for 4 wk. Blood and saliva samples were taken before and after the 4 weeks and analyzed for a variety of blood and saliva measures relevant to health promotion. RESULTS: Curcumin, but not placebo, produced the following statistically significant changes: lowering of plasma triglyceride values, lowering of salivary amylase levels, raising of salivary radical scavenging capacities, raising of plasma catalase activities, lowering of plasma beta amyloid protein concentrations, lowering of plasma sICAM readings, increased plasma myeloperoxidase without increased c-reactive protein levels, increased plasma nitric oxide, and decreased plasma alanine amino transferase activities. CONCLUSION: Collectively, these results demonstrate that a low dose of a curcumin-lipid preparation can produce a variety of potentially health promoting effects in healthy middle aged people. https://greenmedinfo.com/article/diverse-effects-low-dose-supplement-lipidated-curcumin-healthy-middle-aged-peo#comments ALT: Elevated Curcumin: Lipidated Oxidative Stress Plasma beta amyloid protein concentrations: elevated Plasma catalase activities: elevated Salivary amylase levels: elevated Soluble cell adhesion molecules (sCAMs): elevated Triglycerides: Elevated Nitric Oxide Enhancer Human Study Thu, 01 Nov 2012 19:13:44 +0000 greenmedinfo 84164 at https://greenmedinfo.com Fermented turmeric powder is well-tolerated and effective in subjects with elevated alanine transaminase levels. https://greenmedinfo.com/article/fermented-turmeric-powder-well-tolerated-and-effective-subjects-elevated-alani PMID:  BMC Complement Altern Med. 2013 ;13:58. Epub 2013 Mar 8. PMID: 23497020 Abstract Title:  The effectiveness of fermented turmeric powder in subjects with elevated alanine transaminase levels: a randomised controlled study. Abstract:  BACKGROUND: Previous animal studies have shown that Curcuma longa (turmeric) improves liver function. Turmeric may thus be a promising ingredient in functional foods aimed at improving liver function. The purpose of the study is to investigate the hepatoprotective effect of fermented turmeric powder (FTP) on liver function in subjects with elevated alanine transaminase (ALT) levels.METHODS: A randomised, double-blind, placebo-controlled trial was conducted between November 2010 and April 2012 at the clinical trial center for functional foods of the Chonbuk National University Hospital. The trial included 60 subjects, 20 years old and above, who were diagnosed mild to moderate elevated ALT levels between 40 IU/L and 200 IU/L. Sixty subjects were randomised to receive FTP 3.0 g per day or placebo 3.0 g per day for 12 weeks. The treatment group received two capsules of FTP three times a day after meals, for 12 weeks. The primary efficacy endpoint was change in the ALT levels in the two groups. The secondary efficacy endpoints included its effect on aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), total bilirubin (TB), and lipid profiles. Safety was assessed throughout the study using ongoing laboratory tests. Adverse events (AEs) were also recorded.RESULTS: Sixty subjects were randomised in the study (30 into the FTP group, 30 into the placebo group), and among them, twelve subjects were excluded from the analysis for protocol violation, adverse events or consent withdrawal. The two groups did not differ in baseline characteristics. After 12 weeks of treatment, 48 subjects were evaluated. Of the 48 subjects, 26 randomly received FTP capsules and 22 received placebo. The FTP group showed a significant reduction in ALT levels after 12 weeks of treatment compared with the placebo group (p = 0.019). There was also observed that the serum AST levels were significantly reduce in the FTP group than placebo group (p = 0.02). The GGT levels showed a tendency to decrease, while the serum alkaline phosphatase (ALP), TB, and lipids levels were not modified. There were no reported severe AEs during this study, or abnormalities observed on blood glucose, total protein, albumin, blood urea nitrogen (BUN), and creatinine levels.CONCLUSION: The data of this trial indicate that FTP is effective and safe, generally well-tolerated without severe AEs, in the treatment of subjects with elevated ALT levels over a 12 weeks period.TRIAL REGISTRATION: ClinicalTrials.gov: NCT01634256 https://greenmedinfo.com/article/fermented-turmeric-powder-well-tolerated-and-effective-subjects-elevated-alani#comments ALT: Elevated Chemically-Induced Liver Damage Turmeric: Fermented Hepatoprotective Phytotherapy Human Study Fri, 12 Jul 2013 15:56:29 +0000 greenmedinfo 104123 at https://greenmedinfo.com Fingolimod has been linked to a wide variety of side effects, including fatal viral infection. https://greenmedinfo.com/article/fingolimod-has-been-linked-wide-variety-side-effects-including-fatal-viral-inf PMID:  N Engl J Med. 2010 Feb 4;362(5):402-15. Epub 2010 Jan 20. PMID: 20089954 Abstract Title:  Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. Abstract:  BACKGROUND: Fingolimod (FTY720), a sphingosine-1-phosphate-receptor modulator that prevents lymphocyte egress from lymph nodes, showed clinical efficacy and improvement on imaging in a phase 2 study involving patients with multiple sclerosis. METHODS: In this 12-month, double-blind, double-dummy study, we randomly assigned 1292 patients with relapsing-remitting multiple sclerosis who had a recent history of at least one relapse to receive either oral fingolimod at a daily dose of either 1.25 or 0.5 mg or intramuscular interferon beta-1a (an established therapy for multiple sclerosis) at a weekly dose of 30 microg. The primary end point was the annualized relapse rate. Key secondary end points were the number of new or enlarged lesions on T(2)-weighted magnetic resonance imaging (MRI) scans at 12 months and progression of disability that was sustained for at least 3 months. RESULTS: A total of 1153 patients (89%) completed the study. The annualized relapse rate was significantly lower in both groups receiving fingolimod--0.20 (95% confidence interval [CI], 0.16 to 0.26) in the 1.25-mg group and 0.16 (95% CI, 0.12 to 0.21) in the 0.5-mg group--than in the interferon group (0.33; 95% CI, 0.26 to 0.42; P https://greenmedinfo.com/article/fingolimod-has-been-linked-wide-variety-side-effects-including-fatal-viral-inf#comments ALT: Elevated Herpes family viruses Herpes Simplex Encephalitis Hypertension Multiple Sclerosis Shingles Skin Cancer Varicella Fingolimod Human Study Sat, 12 Jun 2010 01:45:10 +0000 greenmedinfo 55384 at https://greenmedinfo.com Ginger protects against liver fibrosis. https://greenmedinfo.com/article/ginger-protects-against-liver-fibrosis PMID:  Nutr Metab (Lond). 2011 ;8:40. Epub 2011 Jun 20. PMID: 21689445 Abstract Title:  Zingiber officinale acts as a nutraceutical agent against liver fibrosis. Abstract:  UNLABELLED: ABSTRACT:BACKGROUND/OBJECTIVE: Zingiber officinale Roscoe (ginger) (Zingiberaceae) has been cultivated for thousands of years both as a spice and for medicinal purposes. Ginger rhizomes successive extracts (petroleum ether, chloroform and ethanol) were examined against liver fibrosis induced by carbon tetrachloride in rats.RESULTS: The evaluation was done through measuring antioxidant parameters; glutathione (GSH), total superoxide dismutase (SOD) and malondialdehyde (MDA). Liver marker enzymes; succinate and lactate dehydrogenases (SDH and LDH), glucose-6-phosphatase (G-6-Pase), acid phosphatase (AP), 5&#039;- nucleotidase (5&#039;NT) and liver function enzymes; aspartate and alanine aminotransferases (AST and ALT) as well as cholestatic markers; alkaline phosphatase (ALP), gamma glutamyl transferase (GGT), total bilirubin were estimated. Liver histopathological analysis and collagen content were also evaluated. Treatments with the selected extracts significantly increased GSH, SOD, SDH, LDH, G-6-Pase, AP and 5&#039;NT. However, MDA, AST, ALT ALP, GGT and total bilirubin were significantly decreased.CONCLUSIONS: Extracts of ginger, particularly the ethanol one resulted in an attractive candidate for the treatment of liver fibrosis induced by CCl4. Further studies are required in order to identify the molecules responsible of the pharmacological activity. https://greenmedinfo.com/article/ginger-protects-against-liver-fibrosis#comments ALT: Elevated AST: Elevated Ginger Liver Fibrosis Glutathione Upregulation Malonaldehyde (MDA) Down-Regulation Renoprotective Superoxide Dismutase Up-regulation Animal Study Fri, 09 Sep 2011 20:57:53 +0000 greenmedinfo 68452 at https://greenmedinfo.com Lactobacillus bulgaricus and Streptococcus thermophilus improve liver aminotransferases levels in patients with nonalcoholic fatty liver disease. https://greenmedinfo.com/article/lactobacillus-bulgaricus-and-streptococcus-thermophilus-improve-liver-aminotra PMID:  Eur Rev Med Pharmacol Sci. 2011 Sep ;15(9):1090-5. PMID: 22013734 Abstract Title:  Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial. Abstract:  OBJECTIVE: The present pilot trial was carried out to evaluate the effects of an acute treatment with a mixture containing 500 million of Lactobacillus bulgaricus and Streptococcus thermophilus per day in patients with non alcoholic fatty liver disease (NAFLD).RESEARCH METHODS: A sample of 30 patients with NAFLD (diagnosed by liver biopsy) was enrolled and 28 patients were analyzed in a double blind randomized clinical trial. Patients were randomized to one of the following treatments during 3 months: group I, treated with one tablet per day with 500 million of Lactobacillus bulgaricus and Streptococcus thermophilus and group II, treated with one placebo tablet (120 mg of starch).RESULTS: In group I, alanine amino transferase (ALT: 67.7 +/- 25.1 vs. 60.4 +/- 30.4 UI/L; p https://greenmedinfo.com/article/lactobacillus-bulgaricus-and-streptococcus-thermophilus-improve-liver-aminotra#comments ALT: Elevated Fatty Liver Lactobacilius bulgaricus Streptococcus thermophilus Human Study Sun, 27 Nov 2011 00:52:18 +0000 greenmedinfo 70007 at https://greenmedinfo.com Long term consumption of aspartame causes liver injury and oxidative stress in the rat liver. https://greenmedinfo.com/article/long-term-consumption-aspartame-causes-liver-injury-and-oxidative-stress-rat-l PMID:  Food Chem Toxicol. 2011 Jun ;49(6):1203-7. Epub 2011 Mar 3. PMID: 21376768 Abstract Title:  Effect of long term intake of aspartame on antioxidant defense status in liver. Abstract:  The present study evaluates the effect of long term intake of aspartame, the artificial sweetener, on liver antioxidant system and hepatocellular injury in animal model. Eighteen adult male Wistar rats, weighing 150-175 g, were randomly divided into three groups as follows: first group was given aspartame dissolved in water in a dose of 500 mg/kg b.wt.; the second group was given a dose of 1000 mg/kg b.wt.; and controls were given water freely. Rats that had received aspartame (1000 mg/kg b.wt.) in the drinking water for 180 days showed a significant increase in activities of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP) andγ-glutamyl transferase (GGT). The concentration of reduced glutathione (GSH) and the activity of glutathione peroxidase (GPx), and glutathione reductase (GR) were significantly reduced in the liver of rats that had received aspartame (1000 mg/kg b.wt.). Glutathione was significantly decreased in both the experimental groups. Histopathological examination revealed leukocyte infiltration in aspartame-treated rats (1000 mg/kg b.wt.). It can be concluded from these observations that long term consumption of aspartame leads to hepatocellular injury and alterations in liver antioxidant status mainly through glutathione dependent system. https://greenmedinfo.com/article/long-term-consumption-aspartame-causes-liver-injury-and-oxidative-stress-rat-l#comments ALT: Elevated AST: Elevated Chemically-Induced Liver Damage Oxidative Stress Aspartame Glutathione Down-Regulation Hepatotoxic Oxidant Animal Study Tue, 02 Aug 2011 14:39:24 +0000 greenmedinfo 67578 at https://greenmedinfo.com Loquat seed extract protects against chemically induced liver damage in rats. https://greenmedinfo.com/article/loquat-seed-extract-protects-against-chemically-induced-liver-damage-rats PMID:  Biol Pharm Bull. 2002 Aug;25(8):1053-7. PMID: 12186409 Abstract Title:  Effects of extract derived from Eriobotrya japonica on liver function improvement in rats. Abstract:  Eriobotrya japonica is considered a medicinal plant, and its leaves (Eriobotrya folia) have been used to treat skin diseases, as well as to relieve inflammation, pain, coughing, and sputa. In our evaluation of the pharmacological efficacy of the seed extracts, constituents of the seeds were found to contain the unsaturated fatty acids linolenic and linoleic acids and the sterol beta-sitosterol in the 70% EtOH and the MeOH extracts. The seed extracts were orally administered to rats with dimethylnitrosamine-induced hepatopathy, and blood L-asparate aminotransferase (AST) and L-alanine aminotransferase (ALT) levels, liver retinoid level, and hydroxyproline level were measured. Liver fibrosis rates calculated after Azan-Mallory staining and evaluation of the liver function-improving effects of extracts were showed that AST, ALT, and hydroxyproline levels and liver fibrosis rates were significantly lower, and retinoid levels were significantly higher in hepatopathic rats treated with 70% EtOH and MeOH extracts of the seed than in water-treated control rats. This suggests that the positive effect on liver function of the extracts varies depending on the extracting solvent used. 70% EtOH and MeOH extract of the seeds inhibited the development of liver fibrosis in hepatopathic rats, thus exhibiting potent improvement. The unsaturated linolenic and linoleic acids and the sterol beta-sitosterol contained in these extracts may also contribute to the improvement of liver function. https://greenmedinfo.com/article/loquat-seed-extract-protects-against-chemically-induced-liver-damage-rats#comments ALT: Elevated AST: Elevated Chemically-Induced Liver Damage GGT Loquat Seeds Results for Liver Enzymes: Elevated AST Hepatoprotective Plant Extracts Animal Study Thu, 19 May 2011 02:06:22 +0000 greenmedinfo 63982 at https://greenmedinfo.com Oral magnesium supplementation decreases alanine aminotransferase and hs-CRP levels in obese women. https://greenmedinfo.com/article/oral-magnesium-supplementation-decreases-alanine-aminotransferase-and-hs-crp-l PMID:  Magnes Res. 2010 Jun;23(2):90-6. Epub 2010 May 12. PMID: 20460213 Abstract Title:  Oral magnesium supplementation decreases alanine aminotransferase levels in obese women. Abstract:  To evaluate the effect of oral supplementation with magnesium chloride on the systemic and hepatic inflammation, 38 non-hypertensive obese women aged 30 to 65 years were allocated into groups with and without hypomagnesemia. Hypomagnesemic women drank 50 mL of 5% solution of MgCl(2) equivalent to 450 mg of elemental magnesium. Low-carbohydrate diets and physical activity were indicated for women in both groups. Chronic diarrhea, alcohol intake, use of diuretics, previous oral magnesium supplementation, hepatic disease, and renal damage were exclusion criteria. Hypomagnesemia is defined by serum magnesium concentrations/= 40 U/L, and systemic inflammation by serum high-sensitivity C reactive protein (hs-CRP) concentration&gt;/= 3 mg/L. At baseline (p = 0.06) and final of follow-up (p = 0.80), there were no significant differences by body mass index between the groups in the study. In the same way, at baseline ALT (48.1 +/- 25.5 and 34.6 +/- 24.1 U/L, p = 0.14) and hs-CRP (9.4 +/- 6.0 and 7.9 +/- 5.9 mg/dL, p = 0.47) levels were similar in the supplemented and non-supplemented women. In the magnesium group, ALT (24.3 +/- 10.3 and 34.8 +/- 13.6 U/L, p = 0.02) levels, but not hs-CRP (5.2 +/- 1.9 and 8.0 +/- 5.6 mg/L, p = 0.08) reached significantly lower levels, in the fourth month of treatment, than in women in the control group. The adjusted odds ratios between the improvement in serum magnesium and reduction in ALT and hs-CRP levels were 0.56 (95% CI: 0.3-0.9) and 0.93 (95% CI: 0.6-29.9), respectively. Results of this study show that in hypomagnesemic obese women, oral supplementation with magnesium chloride reduces plasma ALT levels; hs-CRP levels only show a reduction trend. https://greenmedinfo.com/article/oral-magnesium-supplementation-decreases-alanine-aminotransferase-and-hs-crp-l#comments ALT: Elevated C-Reactive Protein GGT Magnesium Obesity Results for Liver Enzymes: Elevated AST Human Study Fri, 03 Sep 2010 17:17:08 +0000 greenmedinfo 56077 at https://greenmedinfo.com Wheat Found To Contribute To Rare Liver Disease In Children https://greenmedinfo.com/blog/wheat-found-contribute-rare-liver-disease-children <div class="copyright">This article is copyrighted by GreenMedInfo LLC, 2013<br/><strong><a href="/greenmedinfocom-re-post-guidelines">Visit our Re-post guidelines</a></strong></div><p class="rtecenter"><img alt="Wheat Found To Contribute To Rare Liver Disease In Children" src="//cdn.greenmedinfo.com/sites/default/files/ckeditor/sayerji/images/hepatitis_wheat.jpg" /></p><p><a href="https://greenmedinfo.com/blog/wheat-found-contribute-rare-liver-disease-children" target="_blank">read more</a></p> https://greenmedinfo.com/blog/wheat-found-contribute-rare-liver-disease-children#comments ALT: Elevated AST: Elevated Cryptogenic Hypertransaminasemia Hepatitis: Autoimmune Dark Side of Wheat Gluten Wheat Fri, 15 Mar 2013 12:00:00 +0000 Sayer Ji 93186 at https://greenmedinfo.com